M1000907 is a selective 5-HT2A receptor antagonist. It may interfere with altered 5-HT2A receptor signaling that contributes to ASD symptoms. Increased 5-HT2A receptor activity in certain brain regions may contribute to repetitive behaviors, so treatment with a selective 5-HT2A receptor antagonist has been proposed to improve cognitive flexibility in individuals with ASD. References: Lacivita E, Perrone R, Margari L, Leopoldo M. Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions. J Med Chem. 2017 Oct 30. doi: 10.1021/acs.jmedchem.7b00965. [Epub ahead of print] PubMed PMID: 29039668.

纯度：≥98%

CAS：880759-45-5